How Britain Makes Billions from Cannabis Today After Criminalizing It in Africa 90 Years Ago.

For 90 years, African citizens have been arrested and imprisoned for possessing a plant that Western pharmaceutical companies now use to generate billions in profit. This is the documented story of how colonial powers criminalized cannabis through racist propaganda, forced those laws on Africa, reversed course when the science became undeniable—and never told Africa the truth.

While Britain Heals, Africa Buries Its Own

In British hospitals, doctors prescribe cannabis-derived medicines under government approval — treating epilepsy, managing chronic pain, easing the suffering of cancer patients. British children experiencing life-threatening seizures are given pharmaceutical-grade cannabinoid treatments, monitored by specialists, protected by law. Their parents sleep at night knowing their child has access to every available option.

In Africa, parents hold their seizing children and pray. They know cannabis-based medicine could help. They have read the research. They have heard the stories. But their government hospitals refuse to offer it. Their doctors are forbidden from prescribing it. And if a desperate mother or father seeks it out on their own, they don't find compassion — they find handcuffs.

British citizens carry medical cannabis ID cards, supported by police guidance, protecting them from arrest — a guarantee that no one will be criminalised for treating their own illness. In Africa, there are no cards. There is no protection. A father carrying cannabis oil for his sick child is not a patient — he is a criminal. He is dragged from his family, thrown into an overcrowded prison, and his children are left without a parent. Not because he committed a crime of violence. Not because he endangered anyone. Because he tried to save his child's life using a medicine that British law already recognises as legitimate.

While British companies build billion-pound empires from medical cannabis — exporting, researching, profiting — African entrepreneurs are locked out of an industry that grows from African soil. While the British economy thrives on cannabis revenue, African nations are desperately searching for ways to stimulate growth, create employment, and lift communities out of poverty. The answer is growing beneath their feet. But colonial-era laws — written by the very nations now profiting from cannabis — still hold Africa in chains.

While British cancer patients access cannabis-derived treatments that ease their nausea, restore their appetite, and give them dignity in their most vulnerable moments — African cancer patients are dying. Not because the medicine doesn't exist. Not because the science is unclear. But because their governments have been told, by the same nations now selling this medicine, that cannabis is dangerous. That it has no medical value. That it must remain illegal.

The injustice is not subtle. It is not complicated. It is this: the nations that criminalised cannabis across Africa are now healing their own people with it — and profiting from it — while Africans die, go to prison, and watch their children suffer.

This is not a policy disagreement. This is a moral emergency.

Latest from HeKa Consultants

February 2026

Africa's Stolen Medicine: The Report Every Government Official Must Read

Our landmark report documenting how colonial powers criminalised cannabis through racist propaganda, built billion-pound industries from the same plant, and never told Africa the truth. Presented to Heads of State across the continent.

Read More →
January 2026

Ghana's Cannabis Landscape: What Investors Need to Know

An overview of Ghana's emerging cannabis regulatory framework, licensing opportunities, and why West Africa's most stable democracy is positioned to become a major player in the global medical cannabis market.

Coming Soon →
December 2025

Trump Reclassifies Cannabis: What It Means for Africa

In December 2025, President Trump signed an executive order moving cannabis from Schedule I to Schedule III — the most significant shift in US cannabis policy in over 50 years. We examine the implications for African cannabis markets.

Coming Soon →

What's happening in global cannabis.

Curated by HeKa Consultants — the latest developments shaping Africa's cannabis opportunity.

MJBizDaily

Germany's Medical Cannabis Market Races Toward 600 Tonnes of Annual Imports

Germany's import volume doubled in 2024 to 72,000 kilograms, with patient numbers surging from 250,000 to nearly 900,000 in just over a year.

February 2026
Prohibition Partners

Africa's Legal Cannabis Industry Valued at $7.1 Billion

Expert analysis places Africa's legal cannabis sector at $7.1 billion, driven by expanding regulatory frameworks across the continent and growing international demand.

January 2026
StratCann

African Producers Undercutting Canadian Wholesale Prices by 50%

Emerging producers in Africa and South America are undercutting Canadian bulk dried flower prices by as much as 50%, reshaping global cannabis trade dynamics.

January 2026
Cannabis Health News

Europe's Medical Cannabis Market Surges Amid Regulatory Reforms

Progressive legislation and expanding patient access are driving unprecedented growth across Europe's medical cannabis markets, with the UK expected to exceed €300 million in 2025.

December 2025
MMJ Daily

Malawi Positions Cannabis as Successor to Failing Tobacco Industry

With tobacco exports declining over the past decade, Malawi has authorised the Cannabis Regulatory Authority to issue cultivation, processing, and export licences to transform the nation's agricultural economy.

December 2025
Empower Africa

Cannabis Cultivation Opportunities Across the African Continent

Africa's favourable climate, proximity to Europe, and low production costs position the continent to compete against established cannabis powerhouses in the growing global medical market.

November 2025